Medios AG

XETRA ILM1.DE

Medios AG Operating Income Margin for the year ending December 31, 2023: 1.76%

Medios AG Operating Income Margin is 1.76% for the year ending December 31, 2023, a -2.25% change year over year. Operating Income Ratio is the proportion of a company's operating income to its net sales, measuring the efficiency of its core business operations in generating profits.

Medios AG Operating Income Margin for the year ending December 31, 2022 was 1.80%, a 59.95% change year over year.
Medios AG Operating Income Margin for the year ending December 31, 2021 was 1.12%, a -26.18% change year over year.
Medios AG Operating Income Margin for the year ending December 31, 2020 was 1.52%, a -45.31% change year over year.
Medios AG Operating Income Margin for the year ending December 31, 2019 was 2.78%, a 23.38% change year over year.

Key data

Date	Operating Income Margin	EBT Margin	Net Income Margin	EBITDA Margin

XETRA: ILM1.DE

Medios AG

CEO	Mr. Matthias Gaertner
IPO Date	Dec. 28, 2007
Location	Germany
Headquarters	Heidestrasse 9
Employees	1,011
Sector	Healthcare
Industries Drugstores & Retail Pharmacies Biotechnology Eyewear Pharmaceuticals

Description

Medios AG, together with its subsidiaries, engages in the wholesale of specialty pharmaceutical drugs in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies; and patient-specific therapies for dispensing individually dosed tablets. The company was founded in 2016 and is based in Berlin, Germany.

Key trends

Past 5 years